Thursday, July 3, 2025

Aphria Enters Polish Market Via Arrangement With ODI Pharma AB

It appears that Aphria Inc (TSX: APHA) (NASDAQ: APHA) is expanding its distribution to Poland. It was announced jointly with ODI Pharma AB this morning that the two firms have entered into a supply agreement for distribution to the country.

Under the terms of the supply agreement, which was entered into via CC Pharma, ODI will have the exclusive right to sell cobranded products under the ODI and Aphria brand names within Poland. While details are slim on specifics, what is known is that the supply agreement is for a period of five years, with annual minimums of 1,200 kilograms of medical cannabis product.

In total, the agreement is for 6,000 kilograms of medical cannabis over the five year term. CC Pharma will also support ODI in securing regulatory approval for import and sale of the co-branded products.

Monetary values of the transaction were not provided.

ODI Pharma is a producer and reseller of finished cannabis products within Europe. with the company placing an emphasis on the Polish cannabis market. The company is currently looking to become the number one provider of cannabis products in Poland.

Aphria Inc last traded at $6.32 on the Nasdaq.


Information for this briefing was found via Sedar and Aphria Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Eastern Europe Central Banks Lead Global Gold-Buying Spree

Eastern European central banks are ramping up gold purchases, with Poland leading global acquisitions as...

Saturday, November 30, 2024, 09:07:00 AM

Aphria To Compensate Aleafia Health $29.1 Million For Failed Supply Agreement

Aleafia Health (TSX: AH) is getting paid. Specifically, it’s getting paid by Aphria Inc (TSX:...

Thursday, June 25, 2020, 09:47:25 AM

Aphria: Canaccord Downgrades Company To Hold From Speculative Buy

Earlier this week, it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray...

Friday, December 18, 2020, 12:05:00 PM

Tilray: Haywood Reiterates Hold Rating, $16.50 Price Target

With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month,...

Wednesday, May 19, 2021, 03:38:00 PM

Aphria One Receives EU-GMP Certification

Aphria Inc (TSX: APHA) (NYSE: APHA) issued a follow up to yesterday’s EU-GMP news this...

Wednesday, January 22, 2020, 09:04:45 AM